Edmund Lau Selected Research

hylan

12/2021	Severe Acute Localized Reactions Following Intra-Articular Hyaluronic Acid Injections in Knee Osteoarthritis.
12/2021	Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World Setting.
7/2021	Factors Associated with Knee Arthroplasty in a Knee Osteoarthritis Patient Cohort Treated with Intra-articular Injections of Hylan G-F 20.
10/2019	Is Intra-Articular Injection of Synvisc Associated with a Delay to Knee Arthroplasty in Patients with Knee Osteoarthritis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edmund Lau Research Topics

Disease

23	Infections 07/2022 - 10/2008
10	Knee Osteoarthritis 01/2022 - 01/2019
4	Pulmonary Arterial Hypertension 01/2024 - 10/2017
4	Heart Failure 06/2023 - 02/2013
3	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 04/2004
3	Inflammation (Inflammations) 12/2021 - 01/2018
2	Hypertension (High Blood Pressure) 06/2023 - 02/2013
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2023 - 02/2013
2	Chronic Renal Insufficiency 06/2023 - 02/2014
2	Morbid Obesity 06/2023 - 12/2019
2	Osteoporosis 06/2023 - 01/2020
2	Pain (Aches) 01/2022 - 07/2021
2	Obesity 01/2018 - 12/2017
2	Pulmonary Hypertension 11/2017 - 02/2015
2	Connective Tissue Diseases (Connective Tissue Disease) 10/2017 - 01/2016
2	Hip Fractures (Intertrochanteric Fractures) 09/2015 - 10/2014
2	Pulmonary Embolism 01/2015 - 08/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2014 - 08/2013
2	Psychotic Disorders (Schizoaffective Disorder) 02/2014 - 02/2013
2	Neoplasms (Cancer) 02/2013 - 04/2007
2	Mesothelioma 04/2007 - 06/2004
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2023
1	Tobacco Use Disorder (Nicotine Dependence) 06/2023
1	Diabetes Mellitus 06/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Hypertrophy 01/2023
1	Vascular Remodeling 01/2023
1	Osteoarthritis 07/2021
1	Opioid-Related Disorders (Opiate Addiction) 11/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 10/2020
1	Rheumatoid Arthritis 01/2020
1	Distal Humeral Fractures 01/2020
1	Pneumonia (Pneumonitis) 12/2019
1	Weight Loss (Weight Reduction) 12/2019
1	Low Back Pain (Lumbago) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 12/2017
1	Congenital Heart Defects (Congenital Heart Defect) 10/2017
1	Wrist Fractures 09/2017
1	Osteoporotic Fractures 09/2017
1	Familial Primary Pulmonary Hypertension 01/2017
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2017
1	Sudden Infant Death (SID) 05/2016
1	Reinfection 01/2016
1	Periprosthetic Fractures 06/2015

Drug/Important Bio-Agent (IBA)

8	Hyaluronic Acid (Hyaluronan)IBA 07/2022 - 01/2019
5	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 11/2020
4	hylanIBA 12/2021 - 10/2019
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2020
2	MetalsIBA 01/2017 - 09/2010
2	Polyethylene (Polythene)IBA 01/2017 - 09/2010
2	3,5-tetrahydroaldosterone sulfate (THAS)IBA 05/2016 - 06/2015
1	ambrisentan FDA Link 01/2024
1	Bosentan (Tracleer)FDA Link 01/2024
1	Endothelin Receptor AntagonistsIBA 01/2024
1	macitentanIBA 01/2024
1	Insulin (Novolin)FDA Link 06/2023
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023
1	disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylateIBA 01/2023
1	riociguatIBA 01/2023
1	Sildenafil Citrate (Viagra)FDA Link 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2023
1	TeaIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	CytokinesIBA 01/2018
1	SteroidsIBA 09/2017
1	potassium channel subfamily K member 3IBA 01/2017
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2017
1	activin receptor type II-A (activin A receptor, type II)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Caveolin 1IBA 01/2017
1	EndoglinIBA 01/2017
1	Prokaryotic Initiation Factor-2IBA 01/2017
1	Alkylating AgentsIBA 02/2015

Therapy/Procedure

11	Knee Replacement Arthroplasty (Total Knee Replacement) 07/2022 - 10/2008
11	Arthroplasty 01/2022 - 10/2008
6	Injections 07/2022 - 09/2017
6	Hip Replacement Arthroplasty (Total Hip Replacement) 08/2013 - 01/2009
5	Therapeutics 01/2023 - 01/2016
2	Prostheses and Implants (Prosthesis) 11/2021 - 01/2021
2	Intra-Articular Injections 07/2021 - 10/2019
2	Bariatric Surgery 12/2019 - 01/2018
2	Spinal Fusion (Spondylosyndesis) 01/2018 - 06/2014
2	Aftercare (After-Treatment) 01/2016 - 09/2015
2	Length of Stay 08/2011 - 10/2008
1	Pain Management 01/2022
1	Viscosupplementation 07/2021
1	Complementary Therapies (Alternative Medicine) 11/2020
1	Fontan Procedure (Fontan Operation) 10/2020
1	Combination Drug Therapy (Combination Chemotherapy) 10/2020
1	Replacement Arthroplasty 01/2018
1	Reoperation 01/2018
1	Arthrodesis 12/2017
1	Drug Therapy (Chemotherapy) 02/2015
1	Chemoprevention 01/2015